SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-013712
Filing Date
2019-09-05
Accepted
2019-09-05 08:05:14
Documents
19
Period of Report
2019-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 79917
2 ex99-1.htm EX-99.1 25207
3 ex99-2.htm EX-99.2 12201
4 ex99-1_001.jpg GRAPHIC 2384
5 ex99-2_001.jpg GRAPHIC 52673
6 ex99-2_002.jpg GRAPHIC 222813
7 ex99-2_003.jpg GRAPHIC 73947
8 ex99-2_004.jpg GRAPHIC 88281
9 ex99-2_005.jpg GRAPHIC 59904
10 ex99-2_006.jpg GRAPHIC 120077
11 ex99-2_007.jpg GRAPHIC 96907
12 ex99-2_008.jpg GRAPHIC 141873
13 ex99-2_009.jpg GRAPHIC 125203
14 ex99-2_010.jpg GRAPHIC 104497
15 ex99-2_011.jpg GRAPHIC 87660
16 ex99-2_012.jpg GRAPHIC 124931
17 ex99-2_013.jpg GRAPHIC 81278
18 ex99-2_014.jpg GRAPHIC 84612
19 ex99-2_015.jpg GRAPHIC 121468
  Complete submission text file 0001493152-19-013712.txt   2307648
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 191076200
SIC: 2835 In Vitro & In Vivo Diagnostic Substances